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1  | BACKGROUND
In seminal fluid, oxidants and antioxidants are secreted by different 
cell types. In particular, leukocytes and immature spermatozoa rep­
resent the main source of reactive oxygen species (ROS). In order to 
accomplish the various physiological processes, the redox balance is 
maintained by an equitable ratio between oxidants and antioxidants 
(Figure 1). On the one hand, a physiological ROS concentration is 
involved in the regulation of many physiological sperm processes 
such as capacitation, acrosome reaction, acquisition of hyperactiva­
tion and sperm–oocyte membrane fusion (Aitken, 2017). However, 
when ROS are generated in excess or in case of limited antioxidant 
concentrations, there can be a shift in the redox potential towards 
oxidative stress.
This article focuses on antioxidants and their role in balancing 
the physiological seminal redox potential. It discusses the evaluation 
of total antioxidant capacity (TAC), as a parameter to evaluate oxi­
dative stress, and the advantages and disadvantages of each metho­
dology for antioxidant assessment. The functional impact of the 
redox imbalance and lower antioxidants levels on sperm parameters 
and their clinical implications in various male infertility conditions 
are described.
1.1 | Antioxidant defence in semen
Antioxidant defences in the ejaculate are localised in spermatozoa 
and seminal plasma. However, during maturation, spermatozoa 
 
Received:	9	January	2020  |  Revised:	3	April	2020  |  Accepted:	10	April	2020
DOI: 10.1111/and.13624  
I N V I T E D  R E V I E W
Total antioxidant capacity—Relevance, methods and clinical 
implications
Sajal Gupta1  |   Renata Finelli1  |   Ashok Agarwal1  |   Ralf Henkel1,2
1American Center for Reproductive 
Medicine, Cleveland Clinic, Cleveland, OH, 
USA
2Department of Medical Bioscience, 
University of the Western Cape, Bellville, 
South Africa
Correspondence
Ashok Agarwal, American Center for 
Reproductive Medicine, Cleveland Clinic, 
Mail Code X­11, 10681 Carnegie Avenue, 
Cleveland, OH 44195, USA.
Email: agarwaa@ccf.org
Abstract
Oxidative stress is pre­empted by an adequate level of antioxidants, which scavenge 
oxidants when they are produced in excess by different sources, including leukocytes 
and immature spermatozoa. Enzymatic antioxidants, such as superoxide dismutase, 
catalase and glutathione peroxidase, and several non­enzymatic antioxidants (pro­
teins, vitamins and minerals), working as oxidant scavengers and cofactors of en­
zymatic antioxidants have been identified in seminal plasma. The total antioxidant 
capacity (TAC) is a diagnostic test that can be utilised in the male infertility workup. 
TAC measures the amount of total antioxidants in seminal plasma. Therefore, it pro­
vides an assessment of the reductive potential in seminal plasma. Several studies 
have investigated the diagnostic application of TAC in various andrology conditions. 
There is substantial evidence in the literature to show that infertile patients have 
lower seminal TAC in comparison with fertile men. Moreover, there is a positive cor­
relation between TAC and seminal parameters, such as sperm concentration, motility 
and morphology. Evaluation of TAC together with reactive oxygen species (ROS) and 
sperm DNA fragmentation index (DFI) may be beneficial in the diagnosis of male 
infertility.
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undergo several morphological changes, resulting in the loss of 
cytoplasm and nuclear DNA compaction. Therefore, their cyto­
plasmic antioxidant fraction is limited, and spermatozoa rely on 
antioxidants in seminal plasma to counteract oxidative stress. 
These can be generally classified as enzymatic and non­enzymatic 
antioxidants.
1.1.1 | Enzymatic antioxidants
Superoxide dismutase (SOD), catalase (CAT) and glutathione per­
oxidase (GPx) are the main enzymatic antioxidants in semen. They 
work synergistically, as SOD converts the superoxide anion (O−
2
) 
into H2O2. CAT and GPx, in turn, convert O
−
2
 into molecular oxygen 
or alcohols, respectively, contributing to the removal of oxidants 
(Kehrer, 2000; Valko, Izakovic, Mazur, Rhodes, & Telser, 2004). 
In the male reproductive tract, three different SOD isoforms are 
produced, thereby contributing to antioxidants scavenging: (a) 
the homodimeric SOD1 is a Cu/Zn­binding enzyme which loca­
lises at the level of mitochondria and cytosol; (b) the mitochondrial 
homotetrameric SOD2 binds to manganese and it is inhibited by 
high levels of peroxy nitrite (MacMillan­Crow & Thompson, 1999); 
and (c) the extracellular homotetrameric Cu/Zn SOD3 isoform has 
been described in extracellular fluids of eukaryotes. They are ex­
pressed in the testis by Sertoli, Leydig and germ cells and in the 
epididymal head and body (Bauché, Fouchard, & Jégou, 1994; Mruk 
et al., 1998). Lower levels of CAT have been detected along the 
epididymal tract and in the testis of rats (Mendis­Handagama, Zirkin, 
Scallen, & Ewing, 1990; Peltola, Huhtaniemi, & Ahotupa, 1992; Zini 
& Schlegel, 1997). Spermatozoa show CAT activity but such activity 
has not been reported in the other stages of sperm development 
(Bauché et al., 1994). Several selenium­dependent and selenium­
independent isoforms of GPx have been described as cytoplasmic, 
membrane­bound or secreted proteins. They work in concert with 
glutathione: the latter acts as electron donor to catalyze the re­
duction of H2O2 in H2O. Several isoforms, such as GPx3 and GPx5, 
are reportedly expressed in the murine epididymal head (Schwaab 
et al., 1995; Zini & Schlegel, 1997), where they bind on the surface 
of spermatozoa, Sertoli and Leydig cells (Luo et al., 2006). In germ 
cells, GPx enzymatic activity has been reported at various stages 
of spermatogenesis, from spermatogonia to mature spermatozoa, 
albeit at low levels (Bauché et al., 1994).
1.1.2 | Non-enzymatic antioxidants
Several non­enzymatic antioxidants have been identified in semi­
nal plasma, such as proteins, vitamins and minerals, working as oxi­
dant scavengers and cofactors of enzymatic antioxidants. Selenium 
and glutathione are some of the most abundant antioxidants, and 
they work as cofactors in concert with GPx isoforms (Majzoub & 
Agarwal, 2018). Low levels of glutathione are synthesised in Sertoli 
and Leydig cells, with a decline in levels with increasing age (Luo 
et al., 2006). Glutathione is highly expressed in spermatocytes and 
spermatids but less in matured spermatozoa (Bauché et al., 1994). 
Zinc is another mineral showing antioxidant properties based on 
its capability to neutralise the actions of transition metals such as 
iron and copper (Powell, 2000). Vitamins, such as the fat­soluble 
tocopherol (vitamin E), protect spermatozoa from oxidative stress, 
counteracting the lipid peroxidation of sperm membranes (Suleiman, 
Elamin Ali, Zaki, El­Malik, & Nasr, 1996). In the same way, water­sol­
uble compounds, such as ascorbic acid (vitamin C) and L­carnitine, 
protect spermatozoa from the lipid and DNA damage induced by 
oxidative stress (Majzoub & Agarwal, 2018). Coenzyme Q10 is a 
quinone expressed in sperm mitochondria and is directly involved in 
the generation of energy (Majzoub & Agarwal, 2018). Therefore, it 
acts as a scavenger of oxidants produced during oxidative phospho­
rylation along the electron transport chain system. Lycopene is an 
organic compound identified in the testis, specifically in Sertoli cells 
and round spermatids (Ferreira et al., 2000; Rao, Ray, & Rao, 2006). 
It is consumed in diet, including vegetables and fruits which are rich 
in this pigment (Durairajanayagam, Agarwal, Ong, & Prashast, 2014). 
Other non­enzymatic antioxidants present at lower concentration 
include uric acid, vitamin B9, β­carotene, hypotaurine and taurine.
F I G U R E  1   Oxidative stress 
results from a disequilibrium between 
antioxidants and reactive oxygen species 
(ROS)
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2  | MECHANISMS BY WHICH 
ANTIOXIDANTS HELP PROTEC T THE 
SPERMATOZOA
Along their journey from the testis to the female reproductive tract, 
spermatozoa are subjected to numerous insults which can limit their 
fertilising potential. Oxidative stress and ROS generation have been 
broadly observed in male infertile patients, as they damage sper­
matozoa structurally and functionally. ROS are able to react with 
any molecular component, triggering the generation of new radical 
mole cules in a self­perpetuating oxidative stress cycle resulting in 
cellular damage.
Extracellular oxidants are responsible for lipid peroxidation 
of sperm membrane, impacting sperm motility and morphology. 
Intracellular ROS can react with proteins, altering the physiological 
pathways by oxidation of substrates, and DNA, causing sperm DNA 
fragmentation (Figure 2). Therefore, antioxidants play an essential 
role in balancing the seminal concentration of oxidants in sperm 
physiology. The protection from oxidative stress is achieved in three 
steps, as described in the following sections.
2.1 | Prevention
Spermatozoa use several strategies to prevent the ROS­mediated 
cellular damage. During the process of spermiogenesis, genomic 
DNA is strictly compacted around protamines, shielding the DNA 
from the action of oxidants. Moreover, the mitochondria, which are 
the main sources of cellular ROS, are localised in the mid­piece and 
are spatially far from the nucleus. This limits the access to sperm 
DNA by ROS such as O−
2
, which cannot cross the membranes with 
lipids as the predominant molecular component. Several enzymes 
contribute to ROS generation with their catalytic action. However, 
enzymatic proteins can be tridimensional and folded in a way that 
prevents the release of generated ROS during their enzymatic 
activi ty. The enzyme cytochrome oxidase, for example, is the last 
component of the electron transport chain. It is associated with iron 
and copper ions and catalyses the reduction of molecular oxygen 
into H2O. Nevertheless, the composition of this hetero­oligomeric 
enzyme prevents the ROS release in the intracellular milieu (Bourens, 
Fontanesi, Soto, Liu, & Barrientos, 2013).
2.2 | Interception
Enzymatic and non­enzymatic systems are involved in the intercep­
tion, or deactivation, of oxidant species, in order to limit their toxic 
activity. Furthermore, they delocalise oxidants in different intracel­
lular compartments, such as the membrane and the aqueous seminal 
plasma, where their effects are less harmful. Phenolic compounds, 
such as α­tocopherol, work as antioxidants, protecting the mem­
branes from lipid peroxidation. Additionally, they react with ascorbic 
acid and thiols to regenerate their reductive potential (Sies, 1993). 
The ROS half­life influences the scavenger capability of antioxidant 
systems: peroxyl radicals, having a half­life of ~7 s, are more likely to 
be deactivated than hydroxyl radical (10–9 s) (Sies, 1993).
F I G U R E  2   Mechanisms of ROS­mediated sperm damage
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2.3 | Repair
Following the ROS­induced sperm damage, the outcomes are deter­
mined by the severity of the damage. The activation of the apoptotic 
pathway occurs in a setting of severe damage, resulting in the elimi­
nation of damaged spermatozoa. If the damage is milder, it is repaired 
by the oocyte. The repair mechanisms of the oxidative stress­related 
damage are very limited in spermatozoa, as they are transcriptionally 
and translationally silent cells (González­Marín, Gosálvez, & Roy, 2012). 
Specifically, no mechanisms to repair DNA damage are available once 
spermiogenesis is completed. This increases the susceptibility of ma­
ture spermatozoa to the oxidative stress­mediated damage. Moreover, 
mature spermatozoa only have a small amount of cytoplasm and are 
therefore dependent on the seminal plasma for antioxidant defences.
3  | ANTIOXIDANT C APACIT Y AND SPERM 
FUNC TION
Low antioxidant levels in seminal plasma lead to oxidative stress, 
which is an important causative factor in idiopathic male infertility. 
Elevated levels of ROS affect the sperm structure and functions and 
these, in turn, lead to reproductive disorders such as fertilisation 
failure or spontaneous miscarriage and/ or recurrent miscarriages 
(Kamkar, Ramezanali, & Sabbaghian, 2018; Opuwari & Henkel, 2016).
Sperm parameters such as sperm count, motility and morphology 
have been reported to show a strong positive correlation with the levels 
of Zinc and TAC, both being significantly lower in infertile men (Badade, 
More, Narshetty, Badade, & Yadav, 2011). TAC levels have been re­
ported to be significantly lower in men whose partners had repeated 
pregnancy loss when compared to fertile men (Kamkar et al., 2018). 
Bassiri et al. reported a significant correlation between abnormal sperm 
function tests, such as higher numbers of chromomycin A3 positive 
spermatozoa and lipid peroxidation levels in infertile men with one 
failed ICSI cycle. This indicates that this group of men may benefit 
from antioxidant supplementation (Bassiri, Nasr­Esfahani, Forozanfar, 
& Tavalaee, 2020).
4  | ME A SUREMENT OF TOTAL 
ANTIOXIDANT C APACIT Y
Total antioxidant capacity is a diagnostic test that can be used in the 
male infertility workup. TAC measures the amount of total antioxi­
dants in seminal plasma. Therefore, it evaluates oxidative stress, pro­
viding an assessment of the reductive potential in seminal plasma. 
The same test can be performed using different approaches which 
are presented in Table 1.
4.1 | Sample collection
The sample is collected by masturbation in a clean plastic cup after 
2–7 days of sexual abstinence, according to the most recent WHO 
guidelines (2010) (WHO, 2010). It is important to collect the entire 
sample without losing any part, and when the sample is collected at 
home, it must be kept at body temperature during the transport and 
delivered no later than 1 hr. Once the sample is liquefied, it is cen­
trifuged at 300 g for 10 min, in order to remove the cell fraction and 
obtain a clear seminal plasma, which can be tested for TAC.
4.2 | Methods for assessing TAC: principles, 
methodology and reference values
Several methods for the assessment of seminal TAC have been pro­
posed in the literature (Table 1). They vary according to the principle 
and methodology as well as their sensitivity to different antioxi­
dants. Therefore, results may vary according to the type of test that 
is used (Vassalle et al., 2004).
4.2.1 | 2,2-Diphenyl-1-Picrylhydrazyl (DPPH)
DPPH provides a spectrophotometric evaluation of TAC at a wave­
length of 515 nm. At room temperature and in alcohol solutions, such 
Technique Principle
2,2­Diphenyl­1­Picrylhydrazyl (DPPH) Spectrophotometric evaluation of reduced 
purple­coloured DPPH
Trolox equivalent antioxidant capacity (TEAC) Spectrophotometric evaluation of oxidised 
blue/green­coloured 2,29­azinobis­(3­ethyl 
benzothiazoline­6­sulphonic acid) (ABTS)
TEAC assay ELISA assay Measurement of oxidised ABTS by ELISA 
assay
Ferric reducing antioxidant power (FRAP) Spectrophotometric evaluation of the 
reduction of the ferric tripyridyltriazine 
(Fe3+ ­ TPTZ) to the blue­coloured ferrous 
analogue (Fe2+ ­ TPTZ)
Enhanced chemiluminescence (ECL) assay Oxidation of luminol and the generation of 
a chemiluminescence signal, detected by a 
luminometer
TA B L E  1   Techniques used to evaluate 
the total antioxidant capacity of seminal 
plasma
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as methanol, ethanol or other organic solvents, DPPH is stable and 
purple­coloured. On the other hand, in the presence of antioxidants, 
DPPH is quickly reduced to 1,1­diphenyl­2­picrylhydrazine and 
thereby loses its colour. Therefore, when the sample is incubated 
in DPPH solution, the resulting colorimetric change is inversely 
proportional to the amount of antioxidants in the sample (Garcia 
et al., 2012). The results, expressed as percentage, are calculated 
considering the absorbance values of samples and control (absorb­
ance value obtained by the incubation of DPPH in methanol without 
the	sample),	according	to	the	following	formula:	 [(Abs	CTRL	−	Abs	
sample): Abs CTRL] × 100 (Subramanian et al., 2018).
In a recent study published in 2018 involving 87 subfertile men 
and 23 fertile men, a cut­off of 77.4% of the TAC levels was pro­
posed to discriminate patients according to their fertility status 
with moderate sensitivity (69%) and specificity (58%) (Subramanian 
et al., 2018).
4.2.2 | Trolox equivalent antioxidant capacity 
(TEAC)
The concentration of antioxidants is assessed with a spectropho­
tometer which evaluates the synthesis of a blue/green­coloured oxi­
dised substrate (Rhemrev et al., 2000).
In this technique, described by Miller, Rice­Evans, Davies, 
Gopinathan, and Milner (1993), the compound 2,29­azino­
bis­(3­ethyl benzothiazoline­6­sulphonic acid) (ABTS) is oxidised 
to ABTS+, after being incubated with metmyoglobin and H2O2. This 
coloured substrate can be quantified spectrophotometrically at a 
wavelength of 750 nm. The colorimetric signal is compared with 
that generated by a standard curve of Trolox (6­hydroxy­2,5,7, 
8­tetramethylchroman­2­carboxylic acid), an ana logue of tocoph­
erol. The antioxidants concentration is obtained indirectly based 
on its capability to inhibit the oxidation of ABTS and to reduce 
the colour of the solution. Results are provided as micromoles of 
Trolox equivalent.
In a study conducted in 2016, Roychoudhury, Sharma, Sikka, and 
Agarwal (2016) analysed TAC in a group of 279 infertile patients and 
46 fertile men with the aim to identify a putative cut­off value to dis­
criminate the patients according to their oxidative seminal status. A 
cut-off	value	≥1,950	µM	Trolox	was	proposed,	showing	relatively	low	
specificity (63.0%) and sensitivity (59.5%) (Roychoudhury et al., 2016).
4.2.3 | Assay-based on formation of ABTS radical: 
ELISA assay
The formation of ABTS radical in TEAC assay is usually detected 
spectrophotometrically. However, an enzyme­linked immunosor­
bent assay (ELISA) can be performed. Although the principle of the 
technique remains the same, the technology used for the detection 
of ABTS+ radical differs. An ELISA reader is equipped with a variable 
number of filters to monitor the standard wavelengths. It allows the 
analysis of multiple samples in a microplate, whereas a spectropho­
tometer analyses one sample at a time and requires more time and a 
larger volume of sample.
4.2.4 | Oxygen radical absorbance capacity (ORAC)
ORAC assay, elaborated by Glazer (1990), is based on the capability 
of antioxidants to inhibit the oxidation of substrates by exogenous 
oxidants.
The	 2,2′-azobis-(2-amidino-propane)	 dihydrochloride	 (AAPH)	
is a powerful oxidant molecule that can induce the synthesis of 
peroxyl radicals (Cao & Prior, 1999). Fluorescent probes, such as 
B­phycoerythrin, fluorescein and H2DCFDA, are used to detect 
peroxyl radicals. Specifically, when they bind to the probes, the 
fluorescence is reduced. Therefore, the antioxidant concentra­
tion is inversely correlated with the decrease in the fluorescence 
observed.
4.2.5 | Spectrophotometric assay: ferric reducing 
antioxidant power (FRAP)
The FRAP assay, as described by Benzie and Strain (1996), is a 
direct test to assess the TAC based on the reduction of the fer­
ric tripyridyltriazine (Fe3+ ­ TPTZ) to the ferrous analogue (Fe2+ 
­ TPTZ) by antioxidants at low pH (Prior & Cao, 1999). In fact, 
antioxidants are able to reduce such molecules the same way as 
they reduce ROS. Therefore, the generation of Fe2+ ­ TPTZ, a blue­
coloured molecule, is used as an indicator of antioxidant potential 
in seminal plasma and it can be easily analysed spectrophotometri­
cally at a wavelength of 593 nm. However, FRAP evaluation does 
not include molecules which cannot reduce Fe3+ ­ TPTZ, like glu­
tathione, an antioxidant in vivo (Prior & Cao, 1999). Results are 
expressed	as	µmol/L,	calculated	in	comparison	with	a	calibration	
curve created with a standard dilution of FeSO47H2O (Vassalle 
et al., 2004).
4.2.6 | Enhanced chemiluminescence (ECL) assays
This test evaluates the concentration of non­enzymatic antioxi­
dants in seminal plasma based on the capacity of endogenous anti­
oxidants to limit the generation of a chemiluminescent signal (Said 
et al., 2003).
As described by Alho and Leinonen in detail (Alho & 
Leinonen, 1999), the reactive solution, horseradish peroxidase (HRP)—
linked immunoglobulins and exogenous H2O2 catalyse the oxidation 
of luminol and the generation of a chemiluminescence signal. The ad­
dition of para­iodophenol to the solution ensures a stable chemilumi­
nescent light. Antioxidants present in the seminal plasma counteract 
the generation of chemiluminescence, and the reduction of the signal 
indirectly provides assessment of the antioxidant concentration in the 
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fluid. In fact, like in TEAC assay, a quantitative measurement is done 
by comparison of the signal obtained with that generated by a stan­
dard curve of Trolox. Results are provided as molar Trolox equivalent. 
The evaluation of TAC by chemiluminescence takes around 45 min 
and requires a sophisticated and expensive luminometer.
5  | CLINIC AL DIAGNOSTIC VALUE OF 
ANTIOXIDANT C APACIT Y
Several studies have investigated the diagnostic application of 
TAC in andrology. Literature reports that infertile patients have 
lower seminal TAC in comparison with fertile men. Furthermore, 
a positive correlation between TAC and seminal parameters, such 
as sperm concentration, motility and morphology, has been re­
ported (Eroglu et al., 2014; Mahfouz, Sharma, Sharma, Sabanegh, 
& Agarwal, 2009; Roychoudhury et al., 2016; Subramanian 
et al., 2018). TAC levels were significantly lower in idiopathic male 
infertility (Eroglu et al., 2014), in astheno­ and oligoasthenoterato­
zoospermic patients (Colagar, Karimi, & Jorsaraei, 2013; Pahune, 
Choudhari, & Muley, 2013), in male partners of couples experienc­
ing idiopathic repeated pregnancy loss (Kamkar et al., 2018) and 
varicocele patients (Giulini, 2009). Evaluation of TAC in male infer­
tility can provide useful information in the decision of treatment. 
For instance, surgical treatment of varicocele was demonstrated 
to improve the seminal redox environment with a significant in­
crease of TAC levels, as observed in case of moderate and high­
grade varicocele (Ozturk et al., 2012). In addition, the evaluation 
of antioxidant concentration can provide information about the 
seminal redox status and identify those patients who could benefit 
from antioxidant supplementation. In fact, some studies reported 
an increase of TAC in asthenoteratozoospermic and oligoasthe­
noteratozoospermic patients following supplementation of alpha­
lipoic acid and zinc sulphate/folic acid, respectively (Haghighian, 
Haidari, Mohammadi­Asl, & Dadfar, 2015; Raigani et al., 2014). 
Moreover, the evaluation of TAC can be informative of the semi­
nal oxidative status in patients exposed to environmental factors 
which can affect spermatogenesis. Patients exposed to high lev­
els of ionising radiations as well as lead showed increased semi­
nal TAC value in comparison with controls, as a compensative 
mechanism in response to the damage (Kasperczyk, Dobrakowski, 
Czuba, Horak, & Kasperczyk, 2015; Kumar et al., 2014). However, 
increased pregnancy rate has not yet been seen based on improve­
ment in TAC.
5.1 | ROS-TAC score and its predictive value in 
discriminating fertile from infertile men
Recently, there has been an increasing number of reports indicating 
oxidative stress as a causative factor of idiopathic male infertility 
(Agarwal et al., 2019). Sharma, Pasqualotto, Nelson, Thomas, and 
Agarwal (1999) suggested a new composite ROS­TAC score for the 
evaluation of seminal oxidative stress based on the principal com­
ponent analysis (Sharma et al., 1999). They analysed the predictive 
power of the ROS­TAC score in comparison with TAC or ROS alone. 
A ROS­TAC value of 50.00 ± 10.00 was reported in fertile men, sig­
nificantly higher than ROS­TAC observed in patients with varicocele, 
varicocele and prostatitis, and idiopathic infertility. Moreover, the 
ROS­TAC score showed a higher power to discriminate patients 
according to their fertility status than did the ROS or TAC para­
meters alone (Sharma et al., 1999). ROS­TAC values <50.00 ± 10.00 
have been reported in patients with varicocele (Saleh, Agarwal, 
Sharma, Nelson, & Thomas, 2002; Saleh et al., 2003) or chronic 
prostatitis (Pasqualotto et al., 2000), as well as in asthenozoo­
spermic (Vatannejad et al., 2017) and idiopathic infertile patients 
(Pasqualotto et al., 2001; Pasqualotto, Sharma, Pasqualotto, & 
Agarwal, 2008) or in association with lifestyle factors such as smok­
ing (Saleh et al., 2002),
6  | CONCLUSION
Oxidative stress is a well­established cause of male infertility and 
its evaluation is of great importance in the workup of male fertility. 
Since oxidative stress arises as a result of the disequilibrium between 
pro­ and antioxidant molecules, the evaluation of TAC provides in­
formation on the redox status of seminal samples. Moreover, it high­
lights the reductive power of endogenous seminal antioxidants to 
counterbalance ROS generation in several clinical andrological con­
ditions associated with oxidative stress.
7  | TAKE-HOME MESSAGE
• Antioxidants play an important role in counterbalancing the ROS 
and their impact on sperm functions and parameters.
• The evaluation of TAC is informative of the seminal redox status 
and can help individualise patient management and selection of 
patients for optimal results with antioxidant supplementation.
• In the workup of male infertility, the evaluation of ROS­TAC score 
has a higher prognostic capacity than do the ROS or TAC parame­
ters individually.
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